PA arc
PA arc PA Consulting Group is a leading global management, systems and technology consulting firm. Committed to innovation, responsive to our clients' needs, and focused on delivery of value, PA designs and delivers innovative solutions to complex business issues.

2004

Pfizer completes acquisition of drug delivery technology venture from PA Consulting Group - 12 November 2004

Pfizer Inc and PA Consulting Group today announced the completion of the transaction in which Pfizer purchased the remaining 90% ownership of Meridica Limited, a drug delivery technology venture, from PA Consulting Group for $125 million and a contingent payment.

Meridica is a drug delivery technology company that designs and develops technologies for the pharmaceutical industry.  It was established by PA Consulting Group, the management, systems and technology consulting firm, in May 2001 as part of the firm's venture program. In October 2003 Pfizer purchased a 10% interest in the company and licensed the rights to Meridica's dry powder inhaler.

For more information, please contact:

Heather Smith
PA Consulting Group
123 Buckingham Palace Road
London
SW1W 9SR
United Kingdom

Tel: +44 20 7312 4975
Fax: +44 20 7312 4639
E-mail: heather.smith@paconsulting.com
 

Notes to editors

1. About PA Consulting Group
PA Consulting Group is a leading management, systems and technology consulting firm. Operating worldwide in more than 35 countries, PA draws on the knowledge and experience of 3,000 people, whose skills span the initial generation of ideas, insights and solutions all the way through to detailed implementation.

PA focuses on creating benefits for clients rather than merely proposing them. Our work is founded on powerful insights into our clients' issues, and in the private sector in particular, on the need to deliver superior shareholder returns. We help accelerate business growth by developing innovative products for our clients and by the application of emerging technology. We deliver major transformation programmes, mobilize human resources, and manage complex IT and technically-challenging programmes.

PA's results-focused approach is founded on a unique commitment to excellence, value and independence:

  • Excellence. We are committed to unremitting excellence and quality in every aspect of our work: in our relationships with our clients, in the client assignments we deliver, and in the people we recruit and develop, who enjoy exciting and rewarding careers at PA.
  • Value. PA's consultants bring an intense focus on delivering value through deep industry insight, the development and application of technology, and our culture of respect, collaboration and flexibility in working with clients.
  • Independence. PA is independent of outsourcing, software, hardware and audit providers. We are the pre-eminent client-side advisor on IT and outsourcing projects, and deliver, in partnership with our clients, business solutions tailored to our clients' needs, rather than solutions pre-determined by commercial alliances. As an employee-owned company, we are answerable to our clients and to ourselves only.
    www.paconsulting.com

2. About Pfizer Inc
Pfizer Inc discovers, develops, manufactures and markets leading prescription medicines for humans and animals, including many of the world’s best-known consumer brands.

3. About Meridica
Meridica is a drug delivery company specialising in the development of creative solutions for inhaled, nasal and parenteral routes of administration. In addition to its unique micro-dosing system for dispensing drug powders, it has developed a novel multi-unit dose dry powder inhaler for the delivery of drugs to the lung for the treatment of respiratory conditions. Meridica is a PA Group Company and is based in Cambridge, UK.
www.meridica.com

  Previous  |    |  Next  |

Sign in |  Register
 
Advanced search
Site map    Help   
 
   
Locations  
 
See also: 

* Initial announcement - Pfizer to purchase drug delivery technology venture from PA Consulting Group

* Financial Times story: PA Consulting's Meridica sold to Pfizer for $125m

* Visit Meridica's Web site